Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 1997

View Archived Issues

Merck & Co. describes avermectin analogue

Thrombin-binding anticoagulant disclosed by Japanese scientists

Fibrinogen receptor antagonists under development at E. Merck

New IL-4 antagonist from Hoechst

Roche describes antiproliferative agents

Merck Frosst discloses leukotriene biosynthesis inhibitors

Chondrex license agreement option exercised

Harvard Scientific to present impotence abstract

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Pramlintide can be mixed with insulin

Cortecs launches Helisal One Step test in U.K.

Theratechnologies divests Pharmetics subsidiary

Four HY-TEC autoimmune test kits approved for U.S. marketing

Generic terfenadine approved for U.S. marketing

Antibody-based collaborative agreement reached by CaT and Lilly

Bristol-Myers Squibb/Cadus collaboration extended

Hyal receives notice of allowance for cardiovascular applications of hyaluronic acid

Clinical results with Natrecor in CHF patients reported in Circulation

Panretin phase I/II data described

Elan/Scherer Zydis formulation license agreement

Genetics Institute/Ontogeny functional genomics agreement

Phase I ConXn data reported

SIBIA Neurosciences/Aurora Biosciences drug discovery technology agreement

Antileukemic bisabolane sesquiterpene isolated from natural sources

Genzyme granted U.S. patent for mutation detection technology

Korean researchers report new immunosuppressant from natural source

Genzyme announces launch of instrument line

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Kimmel Cancer Center's immunological disease therapy progress

New analgesic agent described by Japanese academics

Titan in-licenses antipsychotic drug from HMR

SciClone cystic fibrosis drug cleared for clinical testing

RPR seeks FDA approval for Nasacort-HFA

MedCare opens new U.S. treatment centers for urinary incontinence

Sequus' Amphotec earns 19th marketing approval

Access/Strakan license agreement

Labopharm granted US patent on drug delivery system

Further U.S. patent on Celtrix's SomatoKine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...